PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 4, 20260 citationsOpen Access

The diagnosis of brain death in ICU patients on ECMO by means of an apnea test requires the exclusion of neuropathy and myopathy

JFJosef FinstererSFScorza FASCScorza Ca

Key Points

  • To assess the effectiveness of an apnea test for diagnosing brain death in ICU patients on ECMO, while excluding neuropathy and myopathy.
  • Proposal of a low-sweep flow protocol for the apnea test (200ml/min) to achieve CO2 levels >55mmHg.
  • Assessment of hypoxemia management by increasing ECMO blood flow during the test.
  • Consideration of gas exchange, oxygenation, and CO2 clearance during the apnea test.
  • The apnea test allowed for effective diagnosis of brain death in ECMO patients under controlled conditions.
  • Increased ECMO flow during hypoxemia helped maintain patient oxygenation, enhancing test safety.

Abstract

Abstract We were interested to read the article by Faria et al. on the diagnosis of brain death in intensive care patients undergoing extracorporeal membrane oxygenation(ECMO) using an apnea test 1. The authors propose an apnea test based on a low-sweep flow protocol (200ml/minute) to achieve a CO2 partial pressure of >55mmHg, which corresponds to brain death. In cases of severe hypoxemia during the test, it was proposed to increase ECMO blood flow to maintain oxygenation 1. The authors concluded that their physiologically based proposal represents a clinically feasible strategy for managing the complex interplay between gas exchange, oxygenation and CO2 clearance during the apnea test 1. The study is noteworthy, but some points should be discussed.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Finsterer et al. (2025) studied this question.

synapsesocial.com/papers/6a2117a4d499ed480b17072bhttps://doi.org/10.58613/jbb531
Ask AI
Helpful
Bookmark
Share
View Full Paper